Appendix E - National Coverage Determinations Manual / 220.6.14

Why This Topic Matters

It helps readers determine whether the article affects PET imaging coverage, documentation, and study participation requirements for Medicare patients with certain cancers.

Article Sections

1. FDG PET for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers

   Introduces the National Coverage Determination and identifies the cancer indications addressed in the policy. It also notes the effective date and review history.

2. A. Staging for Invasive Cervical Cancer as an Adjunct to Conventional Imaging

   Covers the cervical cancer staging scenario discussed in the policy and the surrounding Medicare coverage context. The section describes the general setting, related imaging tests, and the coverage framework.

3. B. Brain, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers, and other indications of Cervical Cancer not mentioned in Section A above

   Addresses the other cancer indications named in the determination and the broader coverage-with-evidence-development framework. It also discusses the general characteristics of qualifying prospective clinical studies and CMS notification language.